PL2969005T3 - Atenuowane wirusy grypy i szczepionki - Google Patents
Atenuowane wirusy grypy i szczepionkiInfo
- Publication number
- PL2969005T3 PL2969005T3 PL14763039T PL14763039T PL2969005T3 PL 2969005 T3 PL2969005 T3 PL 2969005T3 PL 14763039 T PL14763039 T PL 14763039T PL 14763039 T PL14763039 T PL 14763039T PL 2969005 T3 PL2969005 T3 PL 2969005T3
- Authority
- PL
- Poland
- Prior art keywords
- vaccines
- influenza viruses
- attenuated influenza
- attenuated
- viruses
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16162—Methods of inactivation or attenuation by genetic engineering
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361794617P | 2013-03-15 | 2013-03-15 | |
EP14763039.6A EP2969005B1 (en) | 2013-03-15 | 2014-03-15 | Attenuated influenza viruses and vaccines |
PCT/US2014/030027 WO2014145290A1 (en) | 2013-03-15 | 2014-03-15 | Attenuated influenza viruses and vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2969005T3 true PL2969005T3 (pl) | 2020-04-30 |
Family
ID=51537937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL14763039T PL2969005T3 (pl) | 2013-03-15 | 2014-03-15 | Atenuowane wirusy grypy i szczepionki |
Country Status (8)
Country | Link |
---|---|
US (2) | US10316294B2 (pl) |
EP (2) | EP2969005B1 (pl) |
CA (1) | CA2906823C (pl) |
DK (1) | DK2969005T3 (pl) |
HK (1) | HK1220656A1 (pl) |
HR (1) | HRP20200012T1 (pl) |
PL (1) | PL2969005T3 (pl) |
WO (1) | WO2014145290A1 (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2969005T3 (da) * | 2013-03-15 | 2020-01-20 | The Resaerch Foundation For The State Univ Of New York | Attenuerede influenzavira og -vacciner |
TWI801328B (zh) * | 2015-07-17 | 2023-05-11 | 香港商港大科橋有限公司 | 包括咪喹莫特的局部調配物之用途 |
AR111770A1 (es) | 2017-05-05 | 2019-08-21 | Elanco Us Inc | Vacuna para enfermedad respiratoria bovina |
CN112574958B (zh) * | 2019-09-28 | 2022-09-09 | 普莱柯生物工程股份有限公司 | 一株h9亚型禽流感病毒分离株及其应用 |
CN112964683B (zh) * | 2021-02-08 | 2022-06-17 | 山西医科大学 | 叶酸修饰氮掺杂石墨烯量子点/银纳米荧光探针的制备方法和应用 |
WO2023102520A1 (en) * | 2021-12-02 | 2023-06-08 | Codagenix Inc. | Parenterally administrable influenza vaccine and uses thereof |
CN114264821B (zh) * | 2021-12-24 | 2024-04-26 | 江南大学 | 检测新型冠状病毒中和抗体的试剂盒及其制备方法与应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005116260A2 (en) | 2004-05-25 | 2005-12-08 | Medimmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase variants |
DK3312272T3 (da) | 2004-10-08 | 2019-12-02 | Us Gov Health & Human Services | Modulering af replikationstilpasning ved brug a mindre optrædende synonyme kodoner |
CA2598884A1 (en) | 2005-02-24 | 2006-10-05 | University Of Massachusetts | Influenza nucleic acids, polypeptides, and uses thereof |
AU2007224430A1 (en) | 2006-03-15 | 2007-09-20 | Intervet International B.V. | Recombinant Newcastle disease virus expressing H5 hemagglutinin of avian influenza virus |
US8778353B2 (en) | 2006-05-01 | 2014-07-15 | Technovax, Inc. | Influenza virus-like particle (VLP) compositions |
CA2659267C (en) | 2006-08-09 | 2016-12-13 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
BRPI0809600B1 (pt) * | 2007-03-30 | 2023-01-24 | The Research Foundation Of State University Of New York | Vírus atenuado útil para vacinas |
WO2011044561A1 (en) | 2009-10-09 | 2011-04-14 | The Research Foundation Of State University Of New York | Attenuated influenza viruses and vaccines |
US8298820B2 (en) | 2010-01-26 | 2012-10-30 | The Trustees Of The University Of Pennsylvania | Influenza nucleic acid molecules and vaccines made therefrom |
US20110184160A1 (en) | 2010-01-26 | 2011-07-28 | Weiner David B | Nucleic acid molecule encoding consensus influenza a hemagglutinin h1 |
WO2012089231A1 (en) | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
SG11201401137TA (en) | 2011-10-07 | 2014-07-30 | Medimmune Llc | Influenza hemagglutinin variants |
EP4190895A1 (en) | 2013-02-08 | 2023-06-07 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization |
DK2969005T3 (da) * | 2013-03-15 | 2020-01-20 | The Resaerch Foundation For The State Univ Of New York | Attenuerede influenzavira og -vacciner |
-
2014
- 2014-03-15 DK DK14763039.6T patent/DK2969005T3/da active
- 2014-03-15 EP EP14763039.6A patent/EP2969005B1/en active Active
- 2014-03-15 WO PCT/US2014/030027 patent/WO2014145290A1/en active Application Filing
- 2014-03-15 US US14/777,204 patent/US10316294B2/en active Active
- 2014-03-15 EP EP19203103.7A patent/EP3653701A1/en active Pending
- 2014-03-15 PL PL14763039T patent/PL2969005T3/pl unknown
- 2014-03-15 CA CA2906823A patent/CA2906823C/en active Active
-
2016
- 2016-07-20 HK HK16108726.6A patent/HK1220656A1/zh unknown
-
2019
- 2019-06-10 US US16/436,475 patent/US11549101B2/en active Active
-
2020
- 2020-01-03 HR HRP20200012TT patent/HRP20200012T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
HK1220656A1 (zh) | 2017-05-12 |
WO2014145290A1 (en) | 2014-09-18 |
US11549101B2 (en) | 2023-01-10 |
US20210009962A1 (en) | 2021-01-14 |
US10316294B2 (en) | 2019-06-11 |
CA2906823C (en) | 2023-01-03 |
EP2969005B1 (en) | 2019-10-16 |
EP2969005A4 (en) | 2016-11-30 |
EP3653701A1 (en) | 2020-05-20 |
HRP20200012T1 (hr) | 2020-03-20 |
EP2969005A1 (en) | 2016-01-20 |
CA2906823A1 (en) | 2014-09-18 |
US20160024477A1 (en) | 2016-01-28 |
DK2969005T3 (da) | 2020-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL261204A (en) | Influenza virus vaccines and their use | |
HK1223110A1 (zh) | 流行性感冒病毒疫苗及其用途 | |
HK1214962A1 (zh) | 流感病毒免疫原性組合物及其應用 | |
ZA201700165B (en) | Influenza virus vaccines and uses thereof | |
HK1222882A1 (zh) | 流感病毒重配 | |
IL240504A0 (en) | Combined vaccine for respiratory syncytial virus and influenza | |
HK1218511A1 (zh) | 乙型流感病毒重配 | |
SG11201610443WA (en) | Influenza virus vaccines and uses thereof | |
HK1220656A1 (zh) | 減弱的流感病毒和疫苗 | |
EP3022298A4 (en) | WAXED INFLUENZA VACCINE AND USES THEREOF | |
EP2974740A4 (en) | VACCINE AGAINST HEPATITIS B | |
IL244354B (en) | Flu vaccine and treatment | |
GB201313201D0 (en) | Virus Detection | |
HK1223644A1 (zh) | 呼吸道合胞病毒半活疫苗 | |
SG11201510617WA (en) | Methods and compositions for dengue virus vaccines | |
HK1217638A1 (zh) | 流感病毒重配 | |
HK1223643A1 (zh) | 呼吸道合胞病毒半活疫苗 | |
HK1201283A1 (en) | Influenza c virus and vaccine | |
GB201301119D0 (en) | Viral vaccines | |
HK1219904A1 (zh) | 針對多種登革病毒亞型的新穎疫苗 | |
SG11201507455WA (en) | Hepatitis b virus vaccines | |
IL249705B (en) | Influenza virus vaccines and their uses | |
IL249704A0 (en) | Influenza virus vaccines and their uses | |
GB201314063D0 (en) | Virus | |
GB201306812D0 (en) | Virus |